Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK settles US antidepressant lawsuit with $2.5 million

September 1, 2004

GlaxoSmithKline has paid $2.5 million to the State of New York in an out-of-court settlement of the lawsuit alleging it …

News

Alarm raised over counterfeit Cialis

August 26, 2004

Patients taking Cialis have been warned that counterfeit versions of the impotence drug are in circulation in the UK, the …

News

Cymbalta launched amid renewed controversy

August 26, 2004

Lilly has launched its new depression treatment Cymbalta in the US, a blockbuster tipped to earn $2 billion by 2008.Cymbalta …

News

Novartis claims Prexige safety advantage over rivals

August 26, 2004

Novartis is preparing its latest blockbuster candidate Prexige for launch around the world by proclaiming its superior side-effect profile to …

News

Industry welcomes broadening of hypertension treatment

August 26, 2004

News

Trust defends Alzheimer’s drug spending review

August 26, 2004

News

New technology in clinical trials

August 25, 2004

Feature

Harnessing the NHS agenda

August 23, 2004

Feature

New study highlights additional benefits of Aricept

August 20, 2004

News

Commission continues pursuit of AstraZeneca

August 19, 2004

News

Barker named new ABPI chief

August 12, 2004

Dr Richard Barker has been named as successor to Dr Trevor Jones as the ABPI's director general.Dr Jones, who has …

News

Novartis to ace competition in new hypertension class

August 12, 2004

Novartis is expected to take the lead in the newest class of hypertension treatments when it launches aliskiren in 2006.Analysts …

News

Sculptra receives FDA approval for HIV patients

August 12, 2004

News

Newcastle stem cell pioneers seeking industry partners

August 12, 2004

News

MabThera use to double with first line indication

August 11, 2004

Roche's cancer drug MabThera (rituximab) has received European approval for a new indication – the first line treatment of indolent …

News

Developing people developing drugs

August 9, 2004

What distinguishes pharma research and development from other high-tech industries? It is an oddity of pharma research R&D that, despite …

Feature

Cautious welcome for government crackdown on extremists

August 5, 2004

News

FDA approves Lipitor for reducing heart attack risk

August 5, 2004

The FDA has approved Pfizer's cholesterol-lowering statin Lipitor for a new indication – the prevention of cardiovascular disease by reducing …

News

Pharma to work with NPC on pre-launch updates

August 4, 2004

News of new medicines on the horizon should be communicated better and earlier to NHS clinicians and managers following a …

News

‘Double boost’ for Seoquel in bipolar disorder and dementia

August 4, 2004

AstraZeneca announced a 'double boost' for its atypical antipsychotic Seroquel as it gained FDA approval for the long-term treatment of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025